MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 108 filers reported holding MEI PHARMA INC in Q3 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $33,000 | -78.8% | 54,445 | -6.7% | 0.00% | – |
| Q4 2021 | $156,000 | -3.1% | 58,383 | 0.0% | 0.00% | – |
| Q3 2021 | $161,000 | -62.2% | 58,383 | -61.0% | 0.00% | -100.0% |
| Q2 2021 | $426,000 | -25.1% | 149,520 | -9.9% | 0.00% | 0.0% |
| Q1 2021 | $569,000 | +29.9% | 165,876 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $438,000 | -9.5% | 165,876 | +7.0% | 0.00% | 0.0% |
| Q3 2020 | $484,000 | -23.9% | 155,004 | +0.6% | 0.00% | 0.0% |
| Q2 2020 | $636,000 | +156.5% | 154,003 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $248,000 | -4.6% | 154,003 | +46.8% | 0.00% | – |
| Q4 2019 | $260,000 | +47.7% | 104,924 | 0.0% | 0.00% | – |
| Q3 2019 | $176,000 | -32.8% | 104,924 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $262,000 | +7.8% | 104,924 | +380.4% | 0.00% | 0.0% |
| Q1 2014 | $243,000 | +38.9% | 21,841 | 0.0% | 0.00% | – |
| Q4 2013 | $175,000 | -9.8% | 21,841 | +27.4% | 0.00% | -100.0% |
| Q3 2013 | $194,000 | +63.0% | 17,141 | +2.4% | 0.00% | – |
| Q2 2013 | $119,000 | – | 16,741 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TLS Advisors LLC | 2,010,285 | $490 | 2.42% |
| Anson Funds Management LP | 10,617,959 | $2,586,535 | 0.43% |
| NEA Management Company, LLC | 8,533,072 | $2,078,656 | 0.12% |
| Boxer Capital, LLC | 2,913,091 | $709,629 | 0.04% |
| Investmark Advisory Group LLC | 136,000 | $33,130 | 0.02% |
| CARLSON CAPITAL L P | 1,180,000 | $287,448 | 0.02% |
| Mesirow Financial Investment Management, Inc. | 20,486 | $4,990 | 0.02% |
| Artal Group S.A. | 1,000,000 | $244 | 0.01% |
| Annandale Capital, LLC | 100,000 | $24 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 4,758,364 | $1,158 | 0.01% |